Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulfonylurea Response in ABCC8 Neonatal Diabetes
NCT02624830Phase 4Unknown
- Sponsor
- Haukeland University Hospital
- Start
- Feb 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glibenclamide in Permanent neonatal diabetes mellitus (PNDM), sponsored by Haukeland University Hospital. Status: unknown.
02
Drugs
glibenclamide
03
Conditions
Permanent neonatal diabetes mellitus (PNDM)
Beyond the preview
Go deeper on NCT02624830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624830.